リウマチ性関節炎に対するレバミゾールによる免疫刺激療法
Lancet (London, England)
|February 21, 1976
まとめ
レバミゾールは,リウマチ性関節炎を効果的に治療し,D-ペニシラミンと匹敵し,プラセボを上回ります. 免疫反応を調節し,患者の疼痛緩和と相関しています.
科学分野:
- 免疫学 免疫学とは
- レウマトロジーの病理学
- 薬理学 薬理学とは
背景:
- リウマチ性関節炎 (RA) は,関節炎によって特徴づけられる慢性的な自己免疫疾患です.
- 現在の治療法は,症状を管理し,病気の進行を遅らせることを目的としています.
- D-ペニシラミン (D-penicillamine) は,確立された疾患変容抗レウマティック薬 (DMARD) である.
研究 の 目的:
- リウマチ性関節炎患者におけるレバミゾールの有効性と免疫調節効果を評価する.
- D-ペニシラミンとプラセボに対するレバミゾールの有効性を比較するために.
- RAにおけるレバミゾールの作用メカニズムを調査する.
主な方法:
- リウマチ性関節炎の34人の患者を対象とした制御試験.
- 臨床有効性,赤血球沈殿率 (ESR),リウマチ因子 (RF),テクネチウム指数の評価.
- 抗炎症効果のための細胞媒介免疫と動物モデルの評価.
主要な成果:
- レバミゾールは,リウマチ性関節炎の治療において,D-ペニシラミンに匹敵し,プラセボに優れている有効性を示しました.
- レバミゾール治療は,ESR,RF,テクネチウム指数の低下をもたらし,疾患を変化させる性質を示唆しました.
- レバミゾールで治療された患者では,細胞媒介免疫の刺激が観察され,痛み緩和と相関していました.
結論:
- レバミゾールは,D-ペニシラミンと類似した特定の抗レウマティック活性を示しています.
- レバミゾールの免疫調節効果は,リウマチ性関節炎における治療効果に寄与する可能性があります.
- 動物の研究では,レバミソールには直接的な抗炎症作用がないが,免疫反応を強めることを示唆している.
関連する概念動画
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...